NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line

Tirapazamine (TPZ, SR4233, WIN 59075) is a bioreductive drug that is activated in regions of low oxygen tension to a cytotoxic radical intermediate. This labile metabolite shows high selective toxicity towards hypoxic cells, such as those found in solid tumours. Under aerobic conditions, redox cycli...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Saunders, M P, Patterson, A V, Chinje, E C, Harris, A L, Stratford, I J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2000
Gaiak:
Regular Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363339/
https://ncbi.nlm.nih.gov/pubmed/10682679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.1999.0977
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak